樂迦、台智雲聯手 再生醫療CDMO導入AI加速研發

2023-12-03 / 記者 吳培安
今(3)日,專注於細胞治療製程開發暨委託開發製造服務(CDMO)的樂迦再生科技(6891),於2023台灣醫療科技展宣布與台智雲展開戰略合作、簽署合作意向書,加入經濟部中小企業處AIHPC超算加速器計畫。 會中,樂迦執行長林世嘉與台智雲總經理吳漢章簽署合作意向書。雙方表示,此次合作將會把樂迦在細胞治療製程開發的專業,與台智雲的先進AI技術與強大的算力資源整合,以實現更高效、更精確的製程控制,期以...

Merck Group's M Lab™ Collaboration Center has arrived in Taipei

2023-12-01 / GlobalBio & Investment
MerckGroup'sMLab™CollaborationCenterhasarrivedinTaipei,shiningaspotlightonthecity'svibrantbiopharmapotential.Experiencethechancetocollaboratewithexpertengineersandscientists,conquerbioph...

Taiwan's First Agri-Food Circular Factory Unveiled!

2023-12-01 / GlobalBio & Investment
Taiwan'sFirstAgri-FoodCircularFactoryUnveiled! Inamilestonemove,thefirst-everAgri-FoodCircularConceptFactorycommencedoperationsintheindustrialzonein #Pingtung.Thefacilityincorporatesa #Compal AIoT...

Discover Taiwan's showcased medical device 'hidden champions' at MEDICA

2023-12-01 / GlobalBio & Investment
FairslikeMEDICAconnectuswithasharedgoalofadvancinghealthcareandwell-being.DiscoverTaiwan'sshowcasedmedicaldevice'hiddenchampions'attheexhibition.https://lnkd.in/gy4UEEAa#MEDICA2023 #MEDICA...

Dr. Ching-Yung Lin : Pioneering Graphen to Power AI Drug Development...

2023-12-01 / GlobalBio & Investment
Dr. Ching-YungLin :Pioneering Graphen toPowerAIDrugDevelopment.Nextyear,anewsubsidiaryisonthehorizon,honinginonProteinKinases. Diveintothefullscooptocatchallthedetails!https://lnkd.in/gst3PyCp #Innova...

BioJapan 2023: Taiwan at the Forefront of Regenerative Medicine

2023-12-01 / GlobalBio & Investment
BioJapan2023:TaiwanattheForefrontofRegenerativeMedicine BioJapan2023,Japan'spremierthree-daybiotechnologyevent,kickedoffatthe PACIFICOYokohama ConventionCenteronOctober11th.AroundtwentyTaiwaneseco...

Real-life “Hanten Jutsushiki”! CiRA Director, Jun Takahashi, Utilizes iPSCs for Brain Treatment

2023-12-01 / GlobalBio & Investment
Real-life“HantenJutsushiki”!CiRADirector,JunTakahashi,UtilizesiPSCsforBrainTreatment JunTakahashi,thedirectorofKyotoUniversity'sCenterforiPSCellandApplication(CiRA)andaprominentfigurei...

Taiwan's Cell Therapy: 20 Years of Progress - Reviewing Current Clinical Trials

2023-12-01 / GlobalBio & Investment
Taiwan'sCellTherapy:20YearsofProgress-ReviewingCurrentClinicalTrials Themuch-debatedRegenerativeMedicineActhasbeenthesubjectofongoingdiscussionsformanyyears.Thoughithasconsolidatedfromthreedraftgu...

AI Revolutionizing Biomedicine: Recent Advances and Healthcare Applications

2023-12-01 / GlobalBio & Investment
AIRevolutionizingBiomedicine:RecentAdvancesandHealthcareApplicationsAIanditsgenerativecapabilitieshavegainedsignificantattention,particularlyinthefieldofbiomedicine,sinceChatGPT'srisetoprominencei...

EirGenix's Development Capacity Extends to CDMO and Biosimilars Across the US, Europe, and Taiwan

2023-12-01 / GlobalBio & Investment
【Editor'sChoice|PreviewofSelectedCompaniesatBIOAsia-Taiwan】EirGenix'sDevelopmentCapacityExtendstoCDMOandBiosimilarsAcrosstheUS,Europe,andTaiwan. EirGenix(6589.TWO)isoneofthefewcompaniesinAsiat...

Hospitals in Taiwan use digital technology to implement medical care

2023-12-01 / GlobalBio & Investment
【Editor'sChoice|Taiwan’sMedicalDevice】Shortenunhealthylifeyears!HospitalsinTaiwanusedigitaltechnologytoimplementmedicalcare TheaveragelifeexpectancyofTaiwanesepeoplehasexceeded80years,butthe...

Medical Taiwan Kicks Off on June 8!

2023-12-01 / GlobalBio & Investment
【Editor'sChoice|Taiwan'sMedicalDevice】MedicalTaiwanKicksOffonJune8!230ExhibitorsandInternationalBuyersfrom60CountriesCreatingInfiniteBusinessesOpportunities MedicalTaiwan,hostedbytheTaiwanExte...